相关实验视频
Updated: Jan 13, 2026

06:15
Interactive Molecular Model Assembly with 3D Printing
Published on: August 13, 2020
10.8K
大型语言模型用于可控制的多属性多目标分子优化
Vishal Dey1, Xiao Hu1, Xia Ning1,2,3,4
1Department of Computer Science and Engineering, The Ohio State University, USA.
概括
研究人员开发了GeLLM4O-Cs,这是一种用于药物设计的新型AI模型,在同时优化多个分子性质方面表现出色. 这一进步解决了当前方法的局限性,使药物开发更有效的分子优化成为可能.
科学领域:
- 计算化学是一种计算化学.
- 人工智能在药物发现中的作用
- 机器学习用于分子优化.
背景情况:
- 现实世界的药物设计需要优化多个分子性质,以满足制药标准.
- 现有的计算方法和调整指令的大型语言模型 (LLM) 难以实现细微的,属性特定的优化目标.
- 这种局限性阻碍了AI在复杂药物开发场景中的实际应用.
研究的目的:
- 为了引入C-MuMOInstruct,第一个指令调整数据集专注于多属性优化,具有明确的,属性特定的目标.
- 开发GeLLM4O-Cs,一系列能够针对性,属性特定的分子优化指令调整的LLM.
- 提高人工智能在现实的药物设计工作流程中的实际应用性.
主要方法:
- 创建C-MuMOInstruct数据集,其中包含针对多个物业优化的物业特定目标.
- 开发了GeLLM4O-Cs,LLMs使用C-MuMOInstruct数据集进行了微调.
- 在5个分布式和5个分布式以外的任务中进行实验性评估,以根据基线评估性能.
主要成果:
- 与强大的基线相比,GeLLM4O-Cs表现出更高的性能,在分子优化任务中成功率高达126%.
- 这些模型表现出强大的0-shot泛化能力,成功地处理了新的优化任务和未见的指令.
- 在各种分布式和分布式外测试案例中,一致的超出性能.
结论:
- GeLLM4O-Cs代表了人工智能驱动的药物设计分子优化的重大进步.
- 开发的模型有效地解决了属性特定的多目标优化挑战.
- 这项工作为基础的LLM铺平了道路,能够支持制药研究中的多样化和现实的优化目标.
相关概念视频
Molecular Models
43.5K
Physical models representing molecular architectures of chemical compounds play essential roles in understanding chemistry. The use of molecular models makes it easier to visualize the structures and shapes of atoms and molecules.
43.5K
Predicting Molecular Geometry
44.7K
VSEPR Theory for Determination of Electron Pair Geometries
44.7K
Mechanistic Models: Compartment Models in Algorithms for Numerical Problem Solving
282
Mechanistic models play a crucial role in algorithms for numerical problem-solving, particularly in nonlinear mixed effects modeling (NMEM). These models aim to minimize specific objective functions by evaluating various parameter estimates, leading to the development of systematic algorithms. In some cases, linearization techniques approximate the model using linear equations.
In individual population analyses, different algorithms are employed, such as Cauchy's method, which uses a...
In individual population analyses, different algorithms are employed, such as Cauchy's method, which uses a...
282
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
238
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
238
Molecules with Multiple Chiral Centers
14.8K
Molecules that possess multiple chiral centers can afford a large number of stereoisomers. For instance, while some molecules like 2-butanol have one chiral center, defined as a tetrahedral carbon atom with four different substituents attached, several molecules like butane-2,3-diol have multiple chiral centers. A simple formula to predict the number of stereoisomers possible for a molecule with n chiral centers is 2n. However, there can be a lower number where some of the stereoisomers are...
14.8K
Multicompartment Models: Overview
497
Multicompartment models are mathematical constructs that depict how drugs are distributed and eliminated within the body. They segment the body into several compartments, symbolizing various physiological or anatomical areas connected through drug transfer processes such as absorption, metabolism, distribution, and elimination.
These models offer a more comprehensive representation of drug behavior in the body than one-compartment models. They accommodate the complexity of drug distribution,...
These models offer a more comprehensive representation of drug behavior in the body than one-compartment models. They accommodate the complexity of drug distribution,...
497

